Skip to main content
Open
Question
Forecasts
Track record
Unknowns
How it works
Sources
FAQ
Menu
← Evidence map
Review
Drugs
2022
Chiglitazar: First Approval.
Emma D Deeks
PubMed ↗
Publisher ↗
No numbers read from the abstract.
17 papers cite it
2022
2023
2024
2025
2026
this paper
pooled it
trial
cites it
Chiglitazar: First Approval. | OpenQuestion